Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
Journal of Immunology (Baltimore, Md. : 1950)|August 3, 2016
First Membrane Proximal External Region-Specific Anti-HIV1 Broadly Neutralizing Monoclonal IgA1 Presenting Short CDRH3 and Low Somatic MutationsFahd Benjelloun, Zeliha Oruc, Nicole Thielens, et al.Alimentary Pharmacology & Therapeutics|April 19, 2021
Early detection of anti-drug antibodies during initiation of anti-tumour necrosis factor therapy predicts treatment discontinuation in inflammatory bowel diseaseQuentin Tournier, Stephane Paul, Nicolas Williet, et al.Inflammatory Bowel Diseases|December 22, 2016
Development and Internal Validation of a Model Using Fecal Calprotectin in Combination with Infliximab Trough Levels to Predict Clinical Relapse in Crohn's DiseaseXavier Roblin, Gerard Duru, Nicolas Williet, et al.Gut|January 26, 2020
Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective randomised trialXavier Roblin, Nicolas Williet, Gilles Boschetti, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 1, 2019
Infliximab therapy intensification upon loss of response: Is there an optimal trough level?Bella Ungar, Zohar Ben-Shatach, Gal Ben-Haim, et al.Journal of Periodontology|August 16, 2021
Gingival tissue as a reservoir for human immunodeficiency virus type 1: Preliminary results of a cross-sectional observational studyYoussouf Sereme, Tábata Larissa S Pólvora, Nicolas Rochereau, et al.Frontiers in Immunology|December 27, 2021
YAP/TAZ: Key Players for Rheumatoid Arthritis Severity by Driving Fibroblast Like Synoviocytes Phenotype and Fibro-Inflammatory ResponseRobin Caire, Estelle Audoux, Guillaume Courbon, et al.Journal of Crohn'S & Colitis|August 25, 2025
Comparing standard versus intensified pneumococcal vaccination regimens in patients with inflammatory bowel disease on biologics: a prospective, multicenter, randomized, open-label studyXavier Roblin, Sophie Vieujean, Stéphane Nancey, et al.Immunological Reviews|June 29, 2020
Modulation of immune responses using adjuvants to facilitate therapeutic vaccinationVirgil Schijns, Alberto Fernández-Tejada, Žarko Barjaktarović, et al.Journal of Crohn'S & Colitis|April 10, 2021
Dose optimisation for Loss of Response to Vedolizumab- Pharmacokinetics and Immune MechanismsBella Ungar, Karin Malickova, Jurij Hanžel, et al.Pageof 7